SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

GSK Wins FDA Approval for Nelkarmi, Targets £40bn Sales

GSK wins FDA approval for Nelkarmi and targets £40bn in sales alongside £1.9bn in cuts.

GSK

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.

Related stories